BridgeBio Pharma Inc.

BridgeBio Pharma Inc. (BBIO) — Form SCHEDULE 13G: Ownership over 5% (passive)

SC 13GBBIOFiled Oct 27, 2026, 1:25 PM ET

About this filing

BridgeBio Pharma Inc. (BBIO) filed Form SCHEDULE 13G (ownership over 5% (passive)) with the SEC on Oct 27, 2026. A Schedule 13G reports a passive investor owning more than 5% of the company.

View original filing on SEC.gov

Key facts

Document: —

More BBIO filings

SC 13G/A
Ownership over 5% (passive) (amendment)
Filed Nov 12, 2026
4
Insider transaction
Filed Nov 3, 2026
10-Q
Quarterly report
Filed Oct 29, 2026
8-K
Current report
Filed Oct 29, 2026
8-K
Current report
Filed Oct 13, 2026
4
Insider transaction
Filed Sep 21, 2026

Not investment advice. Summaries can contain errors; the SEC filing is the official record.